Gland Pharma Ltd - Board Meeting Intimation for Approval Of Audited Financial Results For The Quarter And Financial Year Ended March 31, 2026 And To Consider And Recommend Payment Of Final Dividend, If Any For The Financial Year Ended March 31, 2026

Download	< Back
05:06 PM
Gland Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/05/2026 ,inter alia, to consider and approve Audited Financial Results for the Quarter and financial year ended March 31, 2026 and to consider and recommend payment of Final Dividend, if any for the financial year ended March 31, 2026
View all announcements for Gland Pharma Ltd	Source: BSE India